Electromedical Technologies, Inc Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Electromedical Technologies, Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q2 2024.
  • Electromedical Technologies, Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $231K.
  • Electromedical Technologies, Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$1.33M, a 64.1% increase year-over-year.
  • Electromedical Technologies, Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$2.64M, a 23.9% increase from 2022.
  • Electromedical Technologies, Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$3.47M, a 59.1% increase from 2021.
  • Electromedical Technologies, Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$8.48M, a 119% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$1.33M $231K +$1.69M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$3.02M -$836K -$380K -83.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-14
Q4 2023 -$2.64M -$349K +$481K +58% Oct 1, 2023 Dec 31, 2023 10-K 2024-05-01
Q3 2023 -$3.12M -$377K +$581K +60.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$3.7M -$1.46M -$924K -172% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$2.78M -$456K +$688K +60.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-14
Q4 2022 -$3.47M -$830K +$1.02M +55% Oct 1, 2022 Dec 31, 2022 10-K 2024-05-01
Q3 2022 -$4.48M -$958K +$2.34M +71% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$6.83M -$536K +$239K +30.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-20
Q1 2022 -$7.06M -$1.14M +$1.42M +55.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-20
Q4 2021 -$8.48M -$1.85M -$1.44M -350% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$7.04M -$3.3M -$1.13M -52.1% Jul 1, 2021 Sep 30, 2021 10-Q/A 2022-11-23
Q2 2021 -$5.92M -$775K +$65.7K +7.82% Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-11-23
Q1 2021 -$5.98M -$2.56M -$2.11M -467% Jan 1, 2021 Mar 31, 2021 10-Q/A 2022-11-23
Q4 2020 -$3.87M -$410K +$103K +20.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$3.97M -$2.17M -$1.98M -1038% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$2M -$840K -$619K -279% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$1.38M -$451K +$368K +44.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$1.74M -$513K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$191K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$221K Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-16
Q1 2019 -$819K Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.